ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,446Medicare Part D Prescriptions Filled, Including Refills

Rank: 115 out of 6969

$875K Total Retail Price of All Prescriptions

Rank: 182 out of 6969

686 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

6% of this provider’s 12,175 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
BENAZEPRIL HCL 970 743 10 1 18
DICLOFENAC SODIUM 791 570 10 2 78
AMLODIPINE BESYLATE 764 627 3 4
METFORMIN HCL 736 571 4 7
OMEPRAZOLE 585 445 5 6
SIMVASTATIN 530 419 6 1
ZOLPIDEM TARTRATE 515 358 7 16
FUROSEMIDE 464 369 8 10
IBUPROFEN 405 250 9 29
TRAMADOL HCL 380 204 10 27
JANUVIA 371 263 11 41
GLYBURIDE-METFORMIN HCL 347 265 R 12 92
GABAPENTIN 313 193 13 17
HYDROCHLOROTHIAZIDE 303 214 14 8
ATENOLOL 232 195 15 9
TRADJENTA 230 201 10 16 325
LEVOTHYROXINE SODIUM 206 119 17 5
CLOPIDOGREL 205 144 18 48
NIFEDIPINE ER 197 143 19 95
CLONIDINE HCL 188 158 20 59
GLYBURIDE 176 150 R 21 54
LOSARTAN POTASSIUM 175 137 22 12
WELCHOL 167 124 23 235
TRIAMCINOLONE ACETONIDE 167 108 23 55
DIOVAN 161 117 25 26
CARISOPRODOL 158 42 R 26 69
INSULIN SYRINGE 157 100 27 60
FAMOTIDINE 152 134 28 37
PLAVIX 147 111 29 68
CELEBREX 143 127 30 67
ONGLYZA 141 104 31 164
CARVEDILOL 141 116 31 25
SYMBICORT 140 104 33 149
AMITRIPTYLINE HCL 137 101 R 34 87
SINGULAIR 121 91 35 84
MELOXICAM 120 80 36 36
PAROXETINE HCL 117 78 37 65
NAPROXEN 117 80 37 62
NEXIUM 116 95 39 52
BENICAR 113 94 40 107
METOPROLOL TARTRATE 109 92 41 13
CILOSTAZOL 106 71 42 208
LANTUS 103 63 43 50
AMOXICILLIN 92 52 44 99
METOCLOPRAMIDE HCL 92 74 44 136
LOSARTAN-HYDROCHLOROTHIAZIDE 90 69 46 53
PANTOPRAZOLE SODIUM 89 82 47 31
TRIBENZOR 82 54 48 359
GLIPIZIDE 81 77 49 21
ATORVASTATIN CALCIUM 81 41 49 11
DONEPEZIL HCL 77 77 51 32
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 49 52 114
CIPROFLOXACIN HCL 73 47 52 64
PENTOXIFYLLINE 73 63 52 310
WARFARIN SODIUM 67 63 55 20
ENABLEX 67 61 55 299
LEVEMIR 66 54 57 232
PROAIR HFA 66 45 57 33
DOXAZOSIN MESYLATE 63 57 59 74
SUCRALFATE 62 45 60 247
ALENDRONATE SODIUM 62 53 60 14
LISINOPRIL 62 60 60 2
DEXILANT 58 39 63 110
DIOVAN HCT 58 57 63 57
FINASTERIDE 57 57 65 80
MEGESTROL ACETATE 57 54 R 65 129
NOVOLOG MIX 70-30 56 50 67 324
VIMOVO 53 52 68 404
PHENYTOIN SODIUM EXTENDED 53 41 68 169
ENALAPRIL MALEATE 52 35 70 56
OXYBUTYNIN CHLORIDE 52 42 70 126
NIFEDIAC CC 50 49 72 248
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.